360b / Shutterstock.com
US anti-cancer company Juno Therapeutics and a children’s hospital have settled their patent licensing suit with pharmaceutical business Novartis and the trustees of the University of Pennsylvania.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Novartis, Juno, licensing agreement, cancer, CAR-T